Matthew Becker, who holds the W. Gerald Austen Endowed Chair of Polymer Science and Polymer Engineering at the University of Akron (UA), was inducted into the College of Fellows by the American Institute for Medical and Biological Engineering (AIMBE). The College comprises the top 2 percent of medical and biological engineers in the U.S. for their significant contributions to the field. Becker was honored for developing families of degradable polymers for use in additive manufacturing, regenerative medicine, and drug delivery. Becker is a widely recognized scholar and innovator in organic polymer chemistry and biomaterials. He was elected by peers and members into the College of Fellows, which is among the highest professional distinctions accorded to medical and biological engineers. Two degradable polymer platforms from Becker's lab, developed for regenerative medicine and 3D printing, were recently exclusively licensed by 21MedTech from the University of Akron Research Foundation. At its onset, the deal represents one of the most significant licensing arrangements by UA in its 148-year history. Becker's pioneering research at UA into America's deadly opioid epidemic was awarded $2 million in December from the state of Ohio's Third Frontier Commission. UA is working with 21MedTech and pharmaceutical company Merck & Co. Inc. to commercialize a nonopiate degradable polymer mesh designed to control postsurgical pain, which will help patients avoid potential addiction to pain pills.